Study Testing the Addition of Nivolumab Pre and Post Nephrectomy in Patients with Renal Cell Carcinoma (EA8143)
Study Testing the Addition of Nivolumab Pre and Post Nephrectomy in Patients with Renal Cell Carcinoma (EA8143)
Trial Category:
Genitourinary
Phase
III
Contact(s)
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
